HUP9801025A1 - Process for producing sertraline and it's 1,r-stereoisomer - Google Patents
Process for producing sertraline and it's 1,r-stereoisomerInfo
- Publication number
- HUP9801025A1 HUP9801025A1 HU9801025A HUP9801025A HUP9801025A1 HU P9801025 A1 HUP9801025 A1 HU P9801025A1 HU 9801025 A HU9801025 A HU 9801025A HU P9801025 A HUP9801025 A HU P9801025A HU P9801025 A1 HUP9801025 A1 HU P9801025A1
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- dichlorophenyl
- cis
- tetrahydro
- naphthalene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/44—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
- C07C209/52—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of imines or imino-ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Atalálmány tárgya eljárás az (I) képletű cisz-(1R,1S)-N-metil-4-(3,4-diklór-fenil)-1,2,3,4-tetrahidrő-1-naftalin-amin és gyógyászatilagalkalmas savaddíciós sói előállítására a (II) képletű ()-4-(S,R)-[(3,4-diklór-fenil)-3,4-dihidrő-1/2H)-naftalin-1-ilidén]-metil-aminpalládiűmkatalizátőr jelenlétében végzett redűkciója és kívánt esetbena kapőtt (I) képletű bázis gyógyászatilag alkalmas savaddíciós sóvátörténő átalakítása útján, őly módőn, hőgy 5-30tömeg% palládiűmőttartalmazó, hőrdőzóra felvitt, alkálifém-klőriddal előkezeltpalládiűmkatalizátőrt alkalmaznak. A (II) képletű cisz-(1R,1S)-N-metil-4-(3,4-diklór-fenil)-1,2,3,4-tetrahidrő-1-naftalin-amin ismertértékes gyógyászati anyag. Atalálmány szerinti eljárás előnye, hőgy akapőtt termékben a cisz/transz izőmer arány kedvező, és a szennyezőmelléktermékek keletkezése háttérbe szőrűl. ŕThe subject of the invention is the process of cis-(1R,1S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalene-amine of the formula (I) and pharmaceutically suitable acid addition ()-4-(S,R)-[(3,4-dichlorophenyl)-3,4-dihydro-1/2H)-naphthalen-1-ylidene]-methylaminepalladium catalyst of the formula (II) reduction carried out in the presence of and, if desired, by converting the obtained base of formula (I) into a medicinally suitable acid addition salt, in this way, a palladium catalyst containing 5-30 wt. The formula (II) cis-(1R,1S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalene-amine is a medicinal substance of known value. The advantage of the process according to the invention is that the cis/trans isomer ratio in the heat-cooked product is favorable, and the generation of pollutant by-products fades into the background. ŕ
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9801025A HU226424B1 (en) | 1998-05-05 | 1998-05-05 | Process for producing enantiomer mixture for preparation of sertraline |
PCT/HU1999/000036 WO1999057093A1 (en) | 1998-05-05 | 1999-05-05 | Process for the preparation of sertraline and its 1,r-stereoisomer |
AU38403/99A AU3840399A (en) | 1998-05-05 | 1999-05-05 | Process for the preparation of sertraline and its 1,r-stereoisomer |
SK1648-2000A SK16482000A3 (en) | 1998-05-05 | 1999-05-05 | Process for the preparation of sertraline and its 1,r-stereoisomer |
PL99344011A PL344011A1 (en) | 1998-05-05 | 1999-05-05 | Process for the preparation of sertraline and its 1,r-stereoisomer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9801025A HU226424B1 (en) | 1998-05-05 | 1998-05-05 | Process for producing enantiomer mixture for preparation of sertraline |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9801025D0 HU9801025D0 (en) | 1998-06-29 |
HUP9801025A1 true HUP9801025A1 (en) | 2000-08-28 |
HU226424B1 HU226424B1 (en) | 2008-12-29 |
Family
ID=89996511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9801025A HU226424B1 (en) | 1998-05-05 | 1998-05-05 | Process for producing enantiomer mixture for preparation of sertraline |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU3840399A (en) |
HU (1) | HU226424B1 (en) |
PL (1) | PL344011A1 (en) |
SK (1) | SK16482000A3 (en) |
WO (1) | WO1999057093A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN191358B (en) | 1998-01-16 | 2003-11-29 | Pfizer Prod Inc | |
IN187170B (en) * | 2000-01-04 | 2002-02-23 | Sun Pharmaceutical Ind Ltd | |
AU2001243634B2 (en) * | 2000-03-14 | 2006-05-25 | Teva Pharmaceutical Industries Ltd. | Novel process for preparing (+)-cis-sertraline |
CA2448499A1 (en) * | 2001-06-15 | 2002-12-27 | Orion Corporation Fermion | A novel process for the preparation of (is-cis) -4-(3, 4-dichlorophenyl) -1, 2, 3, 4 - tetrahydro-n-methyl-1-naphthalenamine |
US6723878B2 (en) | 2001-06-15 | 2004-04-20 | Orion Corporation Fermion | Method for preparing sertraline |
WO2003093217A1 (en) | 2002-04-29 | 2003-11-13 | Teva Pharmaceutical Industries Ltd. | Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof |
ES2242555T1 (en) | 2003-04-14 | 2005-11-16 | Teva Pharmaceutical Industries Limited | HYDROGENATION OF INTERMEDIARIES OF IMINA OF SERTRALINA WITH CATALYSTS. |
CA2537804A1 (en) | 2003-09-05 | 2005-03-17 | Teva Pharmaceutical Industries Ltd | A recycling process for preparing sertraline |
JP2005334870A (en) * | 2004-04-28 | 2005-12-08 | Nippon Nohyaku Co Ltd | Catalyst composition and production method |
WO2005105301A1 (en) * | 2004-04-28 | 2005-11-10 | Nihon Nohyaku Co., Ltd. | Catalyst composition and production process |
US7345201B2 (en) | 2005-02-23 | 2008-03-18 | Teva Pharmaceutical Industries, Ltd. | Processes for preparing sertraline |
EP1885683A2 (en) | 2005-06-03 | 2008-02-13 | Hetero Drugs Limited | A highly stereoselective synthesis of sertraline |
GB0526444D0 (en) * | 2005-12-23 | 2006-02-08 | Sandoz Ag | Sertraline acid addition salt, its prepartion and its use in the preparation of sertraline hydrochloride form ll |
TR200808115T1 (en) * | 2006-04-28 | 2009-03-23 | Sandoz Ag | Process for the Preparation of 4 (S, R) - (3,4-dichlorophenyl) -3,4-dihydro-1 (2H) -naphthalen-1-ylidene] methylamine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
-
1998
- 1998-05-05 HU HU9801025A patent/HU226424B1/en not_active IP Right Cessation
-
1999
- 1999-05-05 SK SK1648-2000A patent/SK16482000A3/en unknown
- 1999-05-05 WO PCT/HU1999/000036 patent/WO1999057093A1/en not_active Application Discontinuation
- 1999-05-05 PL PL99344011A patent/PL344011A1/en unknown
- 1999-05-05 AU AU38403/99A patent/AU3840399A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU3840399A (en) | 1999-11-23 |
PL344011A1 (en) | 2001-09-24 |
WO1999057093A1 (en) | 1999-11-11 |
HU9801025D0 (en) | 1998-06-29 |
HU226424B1 (en) | 2008-12-29 |
SK16482000A3 (en) | 2001-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9801025A1 (en) | Process for producing sertraline and it's 1,r-stereoisomer | |
AU517357B2 (en) | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetra- hydro-1-napthalenamine | |
IL160440A (en) | Dihydropteridinones, method for producing the same and the use thereof as medicaments | |
RS50257B (en) | Asymmetric synthesis of pregabalin | |
BR0013885A (en) | Perfected tablets | |
ATE282033T1 (en) | SYNTHESIS OF BETA-LAPACHONE AND CORRESPONDING INTERMEDIATE PRODUCTS | |
HUP9603493A2 (en) | Process for producing sertraline and intermedier used in this process | |
TW427994B (en) | New bisphosphines as catalysts for asymmetric reactions | |
Rossi et al. | Diastereoselective synthesis of (E)-alkenes and (E)-1, ω-dienes starting from diastereoisomeric mixtures of 1-bromo-1-alkenes: New syntheses of monounsaturated or bridged ring-ketal naturally occurring substances. | |
BG107050A (en) | Method for the preparation of citalopram | |
IL152645A (en) | Method for the preparation of citalopram | |
YU49242B (en) | Process for preparing 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2h)naphthalenone | |
HUP0401577A2 (en) | Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses | |
PL363148A1 (en) | Bifunctional agents possessing antioxidant and antiarrhythmic activity | |
JP2003514794A5 (en) | ||
WO1999055686A3 (en) | Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds | |
JPS5711929A (en) | Production of 1,1-diester or aldehyde | |
HU9701335D0 (en) | Process for producing 1-(3,4-dimethoxy-phenol)-ethanol | |
ES2103681A1 (en) | Process for the preparation of N-methyl-3-phenyl-3-(p- trifluoromethylphenoxy)propylamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC9A | Change of name, address |
Owner name: EGIS GYOGYSZERGYAR NYRT., HU Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |